Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Bersztel A et al. |
Deoxyspergualin is synergistic with cyclosporin A, but not with FK506 in a rat heart allograft transplantation model. |
1995 |
Transplant. Proc. |
pmid:8540095
|
Jonas S et al. |
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. |
1995 |
Clin Transplant |
pmid:8541635
|
Andoh TF et al. |
Functional and structural characteristics of experimental FK 506 nephrotoxicity. |
1995 |
Clin. Exp. Pharmacol. Physiol. |
pmid:8542679
|
Fukunaga T et al. |
Osteogenesis in xenogeneic bone transplantation, using an immunosuppressant. Rabbit-rat experiments. |
1995 |
Acta Orthop Scand |
pmid:8553828
|
Ryffel B et al. |
Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. |
1995 |
Immunopharmacology |
pmid:8557519
|
Stillman IE et al. |
FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. |
1995 |
Lab. Invest. |
pmid:8558840
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
Chaudhuri B et al. |
The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506. |
1995 |
FEBS Lett. |
pmid:7528690
|
Sandborn WJ et al. |
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue. |
1995 |
Hepatology |
pmid:7528712
|
Richter A et al. |
Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. |
1995 |
Biochem. Pharmacol. |
pmid:7531976
|
Coghlan VM et al. |
Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. |
1995 |
Science |
pmid:7528941
|
Marx SO et al. |
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. |
1995 |
Circ. Res. |
pmid:7532117
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Mor E et al. |
Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. |
1995 |
Transplant. Proc. |
pmid:7533363
|
Hemenway CS et al. |
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. |
1995 |
Genetics |
pmid:8582630
|
Senninger N et al. |
Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. |
1995 |
Transplant. Proc. |
pmid:7533364
|
Gonschior AK et al. |
Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. |
1995 |
Ther Drug Monit |
pmid:8585114
|
Loss M et al. |
Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. |
1995 |
Transplant. Proc. |
pmid:7533365
|
Büttemeyer R et al. |
Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. |
1995 |
Ann Plast Surg |
pmid:8585683
|
Lang T et al. |
Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. |
1995 |
Transplant. Proc. |
pmid:7533367
|
Takeda Y et al. |
Effect of FK 506 on the expression of endothelin receptor mRNA in the vasculature. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587392
|
O'Rourke M et al. |
Recovery of delayed-type hypersensitivity following liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533369
|
Goodall T et al. |
FK506-induced endothelin release by cultured rat mesangial cells. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587453
|
Gaweco AS et al. |
Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression. |
1995 |
Transplant. Proc. |
pmid:7533370
|
Soldin SJ |
Receptor (immunophilin-binding) assay for immunosuppressive drugs. |
1995 |
Ther Drug Monit |
pmid:8588223
|
Armstrong VW et al. |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533371
|
Thomson AW et al. |
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. |
1995 |
Ther Drug Monit |
pmid:8588225
|
Martinez OM et al. |
Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533372
|
Fung JJ and Starzl TE |
FK506 in solid organ transplantation. |
1995 |
Ther Drug Monit |
pmid:8588226
|
Chakraborty TK et al. |
Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand. |
1995 |
Chem. Biol. |
pmid:9383417
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Saito S et al. |
The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft. |
1995 |
Transplant. Proc. |
pmid:7533420
|
Tashiro H et al. |
Monitoring for engraftment of rat orthotopic liver transplantation by semiquantitative PCR. |
1995 |
Transplant. Proc. |
pmid:7533421
|
Shirakata Y et al. |
The minimum graft size for successful orthotopic partial liver transplantation in the canine model. |
1995 |
Transplant. Proc. |
pmid:7533422
|
Kumano K et al. |
Role of endothelin in FK 506-induced renal hypoperfusion in rats. |
1995 |
Transplant. Proc. |
pmid:7533423
|
Izutani H et al. |
Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. |
1995 |
Transplant. Proc. |
pmid:7533425
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Laskow DA et al. |
Phase II FK 506 multicenter concentration control study: one-year follow-up. |
1995 |
Transplant. Proc. |
pmid:7533431
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Bakhtiar R and Stearns RA |
Studies on non-covalent associations of immunosuppressive drugs with serum albumin using pneumatically assisted electrospray ionization mass spectrometry. |
1995 |
Rapid Commun. Mass Spectrom. |
pmid:7535601
|
Ikeda H and Fujiwara K |
Cyclosporin A and FK-506 in inhibition of rat Ito cell activation in vitro. |
1995 |
Hepatology |
pmid:7535735
|
Grimmond S et al. |
Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1. |
1995 |
Hum. Genet. |
pmid:7535744
|
Jiang H et al. |
Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant. |
1995 |
J. Invest. Dermatol. |
pmid:7535825
|
Atkison P et al. |
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. |
1995 |
Lancet |
pmid:7535875
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Bronster DJ et al. |
Demyelinating sensorimotor polyneuropathy after administration of FK506. |
1995 |
Transplantation |
pmid:7535959
|
Sheppard KE |
Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function. |
1995 |
J. Neuroendocrinol. |
pmid:8748119
|
Iwasaki K et al. |
Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. |
1995 |
Drug Metab. Dispos. |
pmid:7536652
|
Miranker A and Karplus M |
An automated method for dynamic ligand design. |
1995 |
Proteins |
pmid:8749844
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Holmes JA and Twentyman PR |
The activity of deoxyspergualin in multidrug-resistant cells. |
1995 |
Cancer Chemother. Pharmacol. |
pmid:7554042
|
Elitsur Y et al. |
FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system. |
1995 |
Dig. Dis. Sci. |
pmid:7555446
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Kobayashi I et al. |
Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy. |
1995 |
Eur. J. Pediatr. |
pmid:7556338
|
Mañez R et al. |
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. |
1995 |
Transplantation |
pmid:7537400
|
Adachi M et al. |
IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor beta chain. |
1995 |
FEBS Lett. |
pmid:7556630
|
Van Thiel DH et al. |
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7537444
|
David M et al. |
[Occurrence of suspicious changes in cervix cytology in women after liver transplantation]. |
1995 |
Geburtshilfe Frauenheilkd |
pmid:7557217
|
Woodle ES et al. |
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. |
1995 |
Clin Transplant |
pmid:7537988
|
Mills RA et al. |
Topical FK-506 prevents experimental corneal allograft rejection. |
1995 |
Cornea |
pmid:7538061
|
|
[Experimental and clinical studies on the effectiveness of new immunosuppressive agents used in heart transplantation and transplantation-related complications]. |
1995 |
Nihon Kyobu Geka Gakkai Zasshi |
pmid:7561285
|
Lee TK et al. |
Postoperative selective bowel decontamination prevents gram-negative bacterial translocation in small-bowel graft recipients. |
1995 |
J. Surg. Res. |
pmid:7538186
|
Asano K et al. |
Generation of effector T cells in Hymenolepis nana-infected, FK-506-treated BALB/c mice. |
1995 |
Immunol. Lett. |
pmid:7590919
|
Galat A and Metcalfe SM |
Peptidylproline cis/trans isomerases. |
1995 |
Prog. Biophys. Mol. Biol. |
pmid:7538221
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
Jurim O et al. |
Living-donor liver transplantation at UCLA. |
1995 |
Am. J. Surg. |
pmid:7538267
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Ishikawa A et al. |
[A case of tacrolimus-induced glucose intolerance following renal allografting]. |
1995 |
Hinyokika Kiyo |
pmid:7544064
|
Bennett WM |
The nephrotoxicity of immunosuppressive drugs. |
1995 |
Clin. Nephrol. |
pmid:7540121
|
Lochmüller H et al. |
Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7544122
|
Moro A et al. |
Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. |
1995 |
EMBO J. |
pmid:7540135
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Zweifach A and Lewis RS |
Slow calcium-dependent inactivation of depletion-activated calcium current. Store-dependent and -independent mechanisms. |
1995 |
J. Biol. Chem. |
pmid:7540169
|
Rouvière-Fourmy N et al. |
1H and 15N assignment of NMR spectrum, secondary structure and global folding of the immunophilin-like domain of the 59-kDa FK506-binding protein. |
1995 |
Eur. J. Biochem. |
pmid:7544285
|
Brand PL and Brus F |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540240
|
Sakamoto K et al. |
A new assay method for immunosuppressants with a tacrolimus (FK506)-like mode of action. |
1995 |
J. Antibiot. |
pmid:7544337
|
Natazuka T et al. |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540241
|
Lee MJ et al. |
Combined inhibition effects of tacrolimus and methylprednisolone on in vitro human lymphocyte proliferation. |
1995 |
Immunopharmacol Immunotoxicol |
pmid:7544367
|
Dhawan A et al. |
Immunosuppressive drugs and hypertrophic cardiomyopathy. |
1995 |
Lancet |
pmid:7540242
|
Nielsen FT et al. |
Nephrotoxicity of FK-506 in the rat. Studies on glomerular and tubular function, and on the relationship between efficacy and toxicity. |
1995 |
Nephrol. Dial. Transplant. |
pmid:7540737
|
Reichenspurner H et al. |
First experience with FK 506 for treatment of chronic pulmonary rejection. |
1995 |
Transplant. Proc. |
pmid:7540775
|
Yumiba T et al. |
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7540780
|
Matsuo S and Okamoto K |
Enhancement of FK-506 activities by ganglioside (GM3) in vivo. |
1995 |
Life Sci. |
pmid:7545772
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Bolman RM |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients. |
1995 |
Ann. Thorac. Surg. |
pmid:7545888
|
Keenan RJ et al. |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. |
1995 |
Ann. Thorac. Surg. |
pmid:7545889
|
Okamoto M et al. |
In situ proliferating status of mononuclear cells in rat small bowel grafts. |
1995 |
Int J Exp Pathol |
pmid:7547442
|
Sakane T et al. |
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]. |
1995 |
Ryumachi |
pmid:8594659
|
Platz KP et al. |
Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation. |
1995 |
Clin Transplant |
pmid:7549052
|
Hammond TG and Kind CN |
Pancreatic and nephrotoxicity of immunomodulator compounds. |
1995 |
Toxicol. Lett. |
pmid:8597171
|
Mueller AR et al. |
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506? |
1995 |
Clin Transplant |
pmid:7549057
|
Ma J et al. |
Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein. |
1995 |
Biophys. J. |
pmid:8599646
|